Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-04-14 @ 4:30 PM
Study NCT ID:
NCT05667220
Status:
UNKNOWN
Last Update Posted:
2023-01-03
First Post:
2022-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes
Sponsor:
Beijing Chao Yang Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2022-Sitagliptin-Beidougen
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None